Larvol Delta - Prophylactic-Tocilizumab-to-Mitigate-Cytokine-Release-Syndrome-and-Facilitate-Dosing-of-Talquetamab-in-All-Practice-Settings-in-RelapsedRefractory-Multiple-Myeloma-Results-from-Monumental1

Talvey (talquetamab-tgvs) - J&J

Actemra IV (tocilizumab) - Roche, JW Pharma, Chugai Pharmaceutical

https://imsannual2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=TU1XRFNPTlIyMjY0Nw&PosterID=826814&rnd=0.7525425

Aurore Perrot, MD, PhD

Sep 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next